CIK 0001824293 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824369909
- Phone
- (619) 400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-12 | SALMON Pharma GmbH 10% owner | Other acquisition | +47,063 | $6.40 | $301K | 47,063 |
| 2021-02-12 | Thorell Marella Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-02-12 | Baker David Charles Chief Executive Officer | Other acquisition | +7,843 | $6.40 | $50K | 7,843 |
| 2021-02-12 | Baker David Charles Chief Executive Officer | Purchase | +1,000 | $8.00 | $8K | 8,843 |
Page 4 of 4 · 64 trades